This is a post only message. Click here http://www.aei.org/inv020207.htm to register online or print this e-mail, fill it out, and fax it to 202.862.7171. Please do not reply to this e-mail.
HEALTH POLICY DISCUSSION
The OxyContin "Crisis"-Who's to Blame?
Thursday, February 7, 2002, 10:30 a.m.-12:30 p.m.
Wohlstetter Conference Center, Twelfth Floor, AEI
1150 17th Street, N.W., Washington, D.C.
The pharmaceutical drug OxyContin is a potent pain reliever, often the only help for hundreds of thousands of patients who suffer serious, relentless aches. The drug has recently been in the spotlight for its use as a street narcotic, sold on the black market and responsible for addiction and overdose deaths. In nearly all cases OxyContin addicts are established substance abusers and not patients suffering from pain. In order to obtain a heroin-like high, these addicts crush the pill to make it more powerful and fast-acting.
The Drug Enforcement Administration and several state attorneys general are blaming "aggressive marketing" by OxyContin's manufacturer (Purdue Pharma) for what has been called an "Oxy abuse epidemic." Trial lawyers are filing class action suits against the company. Who is responsible for the abuse of OxyContin? This AEI discussion will include:
JOHN E. CALFEE, AEI
WILLIAM ESTEP, Lexington Herald-Leader (invited)
J. DAVID HADDOX, Purdue Pharma L.P.
ERIKA KING, Covington & Burling
SALLY SATEL, AEI
JAMES K. GLASSMAN, AEI
You may register online at www.aei.org/inv020207.htm, or you may fax this form to 202.862.7171, or mail this form to: American Enterprise Institute, Conferences, 1150 17th St., N.W., Washington, D.C. 20036.
I will attend the health policy discussion on February 7.
__Please check if this is a new address.
Registration fee for this event is $5.
Method of payment:
__Check payable to the American Enterprise Institute is enclosed
__I will pay at the door
__Fee waived (member of media, U.S. government employee, AEI supporter)
__Visa __MC __AmEx
Account number: ____________________
Expiration date: _____________________
For additional information, call the health policy events line at 202.862.5865.